O'Connor S - Search Results

1

Human papillomavirus vaccination and cervical cancer risk.

Rahangdale L, Mungo C, O'Connor S, Chibwesha CJ, Brewer NT. Rahangdale L, et al. BMJ. 2022 Dec 15;379:e070115. doi: 10.1136/bmj-2022-070115. BMJ. 2022. PMID: 36521855 Review.

2

Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.

Rohner E, Edelman C, Sanusi B, Schmitt JW, Baker A, Chesko K, Faherty B, Gregory SM, Romocki LS, Sivaraman V, Nelson JAE, O'Connor S, Hudgens MG, Knittel AK, Rahangdale L, Smith JS. Rohner E, et al. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2651-2661. doi: 10.1158/1055-9965.EPI-20-0674. Epub 2020 Sep 17. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32943435 Free PMC article.

3

Utility of p16INK4a expression for the interpretation of uterine cervical biopsies in Kenya.

Muvunyi TZ, Rohner E, O'Connor S, Kalebi AY, Waweru W, Kairu J, Ochuk W, Smith JS, Muchiri LW. Muvunyi TZ, et al. Pan Afr Med J. 2021 Sep 22;40:55. doi: 10.11604/pamj.2021.40.55.21116. eCollection 2021. Pan Afr Med J. 2021. PMID: 34795834 Free PMC article.

4

Can molecular subtyping be used to guide metastatic screening in breast cancer?

O'Connor SM, Lawton TJ. O'Connor SM, et al. Am J Clin Pathol. 2015 Apr;143(4):468-70. doi: 10.1309/AJCPR3BFA2PHSNYD. Am J Clin Pathol. 2015. PMID: 25779996 No abstract available.

5

Clinical and Financial Implications of Second-Opinion Surgical Pathology Review.

Johnson SM, Samulski TD, O'Connor SM, Smith SV, Funkhouser WK, Broaddus RR, Calhoun BC. Johnson SM, et al. Am J Clin Pathol. 2021 Sep 8;156(4):559-568. doi: 10.1093/ajcp/aqaa263. Am J Clin Pathol. 2021. PMID: 33769453

6

Trichogranulomatous mastopathy: Unique pathology in a case of clinical periductal mastitis.

Johnson SM, Yin M, O'Connor SM, Calhoun BC. Johnson SM, et al. Breast J. 2020 Mar;26(3):524-525. doi: 10.1111/tbj.13565. Epub 2019 Sep 8. Breast J. 2020. PMID: 31495034 No abstract available.

7

Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy.

Harter D, O'Connor SM, Hertel JD, Calhoun BC. Harter D, et al. Histopathology. 2023 Sep;83(3):453-464. doi: 10.1111/his.14966. Epub 2023 May 31. Histopathology. 2023. PMID: 37256703

8

Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Rivenbark AG, O'Connor SM, Coleman WB. Rivenbark AG, et al. Am J Pathol. 2013 Oct;183(4):1113-1124. doi: 10.1016/j.ajpath.2013.08.002. Epub 2013 Aug 27. Am J Pathol. 2013. PMID: 23993780 Free PMC article. Review.

9

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.

Allott EH, Cohen SM, Geradts J, Sun X, Khoury T, Bshara W, Zirpoli GR, Miller CR, Hwang H, Thorne LB, O'Connor S, Tse CK, Bell MB, Hu Z, Li Y, Kirk EL, Bethea TN, Perou CM, Palmer JR, Ambrosone CB, Olshan AF, Troester MA. Allott EH, et al. Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):470-8. doi: 10.1158/1055-9965.EPI-15-0874. Epub 2015 Dec 28. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26711328 Free PMC article.

10

Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes.

Blanton KC, Deal AM, Kaiser-Rogers KA, Anders CK, O'Connor SM, Hertel JD, Calhoun BC. Blanton KC, et al. Ann Diagn Pathol. 2020 Oct;48:151576. doi: 10.1016/j.anndiagpath.2020.151576. Epub 2020 Aug 8. Ann Diagn Pathol. 2020. PMID: 32805517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,085 results

Search Page